Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 1/20 | 0.52 |
| ▸ | CASP6 | P55212 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | CA7 | P43166 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL891695 | 0.81 | ALDH1A1 (0.52) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| SCHEMBL357341 | 0.81 | ALDH1A1 (0.52) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| SCHEMBL728576 | 0.81 | ALDH1A1 (0.52) | ALDH1A1ALOX15KDM4EHSD17B10HPGD | |
| SCHEMBL27104316 | 0.80 | ALDH1A1 (0.41) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL11130587 | 0.80 | ALDH1A1 (0.53) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL11130591 | 0.80 | ALDH1A1 (0.53) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL25273832 | 0.79 | G6PD (0.57) | G6PDCASP7CASP6MMP2ALDH1A1 | |
| SCHEMBL7160570 | 0.79 | ALDH1A1 (0.40) | G6PDCASP7CASP6ALDH1A1ALOX15 | |
| SCHEMBL1536427 | 0.79 | ALB (0.43) | G6PDCASP7CASP6ALDH1A1ALOX15 | |
| SCHEMBL7160568 | 0.79 | ALDH1A1 (0.40) | G6PDCASP7CASP6ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11905231-B1 | Solid forms, salts and polymorphs of anti-fibrotic compounds | CERTA THERAPEUTICS PTY LTD (AU) | 2024-02-20 | — | — | US | disclosed |
| EP-2035369-A1 | THERAPEUTIC COMPOUNDS | Fibrotech Therapeutics PTY LTD (AU) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008003141-A1 | THERAPEUTIC COMPOUNDS | FIBROTECH THERAPEUTICS PTY LTD (AU) | 2008-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11905231-B1 | Solid forms, salts and polymorphs of anti-fibrotic compounds | COL2A1, COL1A1, FIBP | G6PD 2592/4885CASP7 575/4885CASP6 685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.